Search

Author/Creator Nehmiz, Gerhard

1. An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150 mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery. Issue 144 (August 2016)

Authors:
Eriksson, Bengt I.; Mikuska, Zsolt; Feuring, Martin; Amiral, Jean; Haertter, Sebastian; Stangier, Joachim; Nehmiz, Gerhard; Weitz, Jeffrey I.
Journal:
Thrombosis research
Issue:
Issue 144(2016)
Page Start:
158
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150 mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery. Issue 144 (August 2016)

Authors:
Eriksson, Bengt I.; Mikuska, Zsolt; Feuring, Martin; Amiral, Jean; Haertter, Sebastian; Stangier, Joachim; Nehmiz, Gerhard; Weitz, Jeffrey I.
Journal:
Thrombosis research
Issue:
Issue 144(2016)
Page Start:
158
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose‐Dependent Glucosuria in Healthy Subjects. Issue 2 (27th March 2013)

Authors:
Seman, Leo; Macha, Sreeraj; Nehmiz, Gerhard; Simons, Gudrun; Ren, Bailuo; Pinnetti, Sabine; Woerle, Hans J.; Dugi, Klaus
Journal:
Clinical pharmacology in drug development
Issue:
Volume 2:Issue 2(2013:Apr.)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Faldaprevir (Bi 201335), Deleobuvir (Bi 207127) and Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: Sound-C1 Final Results. Issue 8 (November 2013)

Authors:
Zeuzem, Stefan; Asselah, Tarik; Angus, Peter; Zarski, Jean-Pierre; Larrey, Dominique; Müllhaupt, Beat; Gane, Ed; Schuchmann, Marcus; Lohse, Ansgar W; Pol, Stanislas; Bronowicki, Jean-Pierre; Roberts, Stuart; Arasteh, Keikawus; Zoulim, Fabien; Heim, Markus; Stern, Jerry O; Nehmiz, Gerhard; Kukolj,...
Journal:
Antiviral therapy
Issue:
Volume 18:Issue 8(2013)
Page Start:
1015
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Faldaprevir combined with peginterferon alfa‐2a and ribavirin in chronic hepatitis C virus genotype‐1 patients with prior nonresponse: SILEN‐C2 trial12. Issue 6 (12th June 2013)

Authors:
Sulkowski, Mark S.; Bourlière, Marc; Bronowicki, Jean‐Pierre; Asselah, Tarik; Pawlotsky, Jean‐Michel; Shafran, Stephen D.; Pol, Stanislas; Mauss, Stefan; Larrey, Dominique; Datsenko, Yakov; Stern, Jerry O.; Kukolj, George; Scherer, Joseph; Nehmiz, Gerhard; Steinmann, Gerhard G.; Böcher, Wulf O.
Journal:
Hepatology
Issue:
Volume 57:Issue 6(2013:Jun.)
Page Start:
2155
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Faldaprevir combined with pegylated interferon alfa‐2a and ribavirin in treatment‐naïve patients with chronic genotype1 HCV: SILEN‐C1 trial12. Issue 6 (12th June 2013)

Authors:
Sulkowski, Mark S.; Asselah, Tarik; Lalezari, Jacob; Ferenci, Peter; Fainboim, Hugo; Leggett, Barbara; Bessone, Fernando; Mauss, Stefan; Heo, Jeong; Datsenko, Yakov; Stern, Jerry O.; Kukolj, George; Scherer, Joseph; Nehmiz, Gerhard; Steinmann, Gerhard G.; Böcher, Wulf O.
Journal:
Hepatology
Issue:
Volume 57:Issue 6(2013:Jun.)
Page Start:
2143
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗